Picture of Revelation Biosciences logo

REVB — Revelation Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Revelation Biosciences Gemini Induced Statistically Significant, Dose Dependent Changes In Circulatory Il-10 At 2 Hours Post-Dose

Sept 24 (Reuters) - Revelation Biosciences Inc  REVB.O :
    * REVELATION BIOSCIENCES: GEMINI INDUCED STATISTICALLY
SIGNIFICANT, DOSE DEPENDENT CHANGES IN CIRCULATORY IL-10 AT 2
HOURS POST-DOSE
    * REVELATION BIOSCIENCES INC:  COMMITTED TO MOVING RAPIDLY
INTO
PHASE 1B STUDY IN LATE 2024 OF GEMINI

Source text for Eikon:  ID:nBwNfh5wa 
Further company coverage:  REVB.O 

 ((Reuters.Briefs@thomsonreuters.com))

Recent news on Revelation Biosciences

See all news